☆ 4.7 Editorial Material

Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post-2021 Guidelines: Are Economic Barriers Finally Coming Down?

CLINICAL INFECTIOUS DISEASES (2022)

Medicare Prescription Plans Limit Access to Recommended Drugs for Clostridioides difficile Infection

Deanna Buehrle et al.

Summary: Based on the analysis of June 2021 data, oral vancomycin and fidaxomicin are widely used treatments for Clostridioides difficile, but only a small percentage of enrollees have easy access to them.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

Stuart Johnson et al.

Summary: This clinical practice guideline is a focused update on the management of Clostridioides difficile infection (CDI) in adults, specifically addressing the use of fidaxomicin and bezlotoxumab. The recommendations from the multidisciplinary panel are based on evidence derived from systematic literature reviews, aiming to guide healthcare professionals caring for adults with CDI.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Microbiology

Clostridium difficile PCR Cycle Threshold Predicts Free Toxin

Fiona Senchyna et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2017)

添加到收藏夹

Article Immunology

Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin

Kristen L. Bunnell et al.

OPEN FORUM INFECTIOUS DISEASES (2017)

添加到收藏夹

Article Economics

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report-Part I

Joel W. Hay et al.

VALUE IN HEALTH (2010)

添加到收藏夹

Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post-2021 Guidelines: Are Economic Barriers Finally Coming Down?

相关参考文献

Medicare Prescription Plans Limit Access to Recommended Drugs for Clostridioides difficile Infection

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

Clostridium difficile PCR Cycle Threshold Predicts Free Toxin

Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report-Part I

导出引文

分享论文